{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:33:44Z","timestamp":1766810024866,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015990","name":"Sanofi K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004784","name":"SAS Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019271","name":"Kyorin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jtocrr.2022.100392","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T18:51:03Z","timestamp":1659984663000},"page":"100392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)"],"prefix":"10.1016","volume":"3","author":[{"given":"Nobuyasu","family":"Awano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riken","family":"Kawachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari S.","family":"Oba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kunitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2022.100392_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtocrr.2022.100392_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1213\/ANE.0000000000002183","article-title":"Perioperative venous thromboembolism: a review","volume":"125","author":"Gordon","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtocrr.2022.100392_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jtocrr.2022.100392_bib7","first-page":"6s8","article-title":"Cancer and thrombosis: new insights to an old problem","volume":"45","author":"Leiva","year":"2020","journal-title":"J\u00a0Med Vasc"},{"key":"10.1016\/j.jtocrr.2022.100392_bib8","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.bjc.6601964","article-title":"Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study","volume":"91","author":"Murchison","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtocrr.2022.100392_bib10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jtho.2020.04.033","article-title":"Impact of ALK rearrangement on venous and arterial thrombotic risk in NSCLC","volume":"15","author":"Al-Samkari","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib11","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer therapy\u2013associated thrombosis","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/jnci\/djs435","article-title":"Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis","volume":"104","author":"Proverbs-Singh","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtocrr.2022.100392_bib13","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","article-title":"Risk of venous thromboembolism in patients with cancer treated with cisplatin: a systematic review and meta-analysis","volume":"30","author":"Seng","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jth.15272","article-title":"Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Icht","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtocrr.2022.100392_bib15","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"Nalluri","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jtocrr.2022.100392_bib16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood.2020007878","article-title":"Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy","volume":"137","author":"Moik","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtocrr.2022.100392_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1358863X14568705","article-title":"Approach to chemotherapy-associated thrombosis","volume":"20","author":"Oppelt","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jtocrr.2022.100392_bib18","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"suppl 4","key":"10.1016\/j.jtocrr.2022.100392_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","author":"White","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtocrr.2022.100392_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.thromres.2021.09.012","article-title":"One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: results from the Cancer-VTE Registry","volume":"213","author":"Ohashi","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtocrr.2022.100392_bib21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jjco\/hyaa112","article-title":"Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry","volume":"50","author":"Ohashi","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018910","article-title":"Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry)","volume":"8","author":"Ohashi","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtocrr.2022.100392_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12185-008-0047-x","article-title":"Negative predictive value of D-dimer for diagnosis of venous thromboembolism","volume":"87","author":"Nomura","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib24","first-page":"33","article-title":"Criteria for ultrasound diagnosis of deep venous thrombosis of lower extremities","volume":"35","author":"Tanaka","year":"2008","journal-title":"J\u00a0Med Ultrason (2001)"},{"key":"10.1016\/j.jtocrr.2022.100392_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/bjc.2016.143","article-title":"Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data","volume":"115","author":"Walker","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtocrr.2022.100392_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-020-06930-1","article-title":"Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study","volume":"20","author":"Howlett","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtocrr.2022.100392_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtocrr.2022.100392_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/cam4.3670","article-title":"Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study","volume":"10","author":"Kenmotsu","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtocrr.2022.100392_bib29","first-page":"110","article-title":"Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients","volume":"75","author":"Hiraide","year":"2020","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jtocrr.2022.100392_bib30","first-page":"454","article-title":"[Risk factors of lung cancer complicated with symptomatic venous thromboembolism]","volume":"39","author":"Gong","year":"2016","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.jtocrr.2022.100392_bib31","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtocrr.2022.100392_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-018-0791-2","article-title":"Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer","volume":"19","author":"Dou","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jtocrr.2022.100392_bib33","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.2147\/CMAR.S301088","article-title":"Association of venous thromboembolism and early mortality in patients with newly diagnosed metastatic non-small cell lung cancer","volume":"13","author":"Su","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jtocrr.2022.100392_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0079-2021","article-title":"Recent developments in the treatment of small cell lung cancer","volume":"30","author":"Hiddinga","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jtocrr.2022.100392_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:56Z","timestamp":1762987076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2666364322001163"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100392","relation":{},"ISSN":["2666-3643"],"issn-type":[{"type":"print","value":"2666-3643"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100392"}}